Form 4 for GH Guardant Health, Inc.
Accepted 2022-03-14 00:00:00 ET · period of report 2022-03-10 · accession 0000899243-22-010947 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-14 | 2022-03-10 | GH | MERESMAN STANLEY J | Dir | S - Sale+OE | $58.74 | -4,934 | 4,059 | -55% | -$289.8K |
| D | 2022-03-14 | 2022-03-10 | GH | MERESMAN STANLEY J | Dir | M - OptEx | $5.94 | +4,934 | 8,993 | +122% | +$29.3K |
| D | 2022-03-14 | 2022-03-10 | GH | MERESMAN STANLEY J | Dir | M - OptEx | $5.94 | -4,934 | 9,869 | -33% | -$29.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2022-03-10 | S | D | 4,934 | $58.74 | 4,059 | D | — | — | (F1) These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
| 2 | Common | COMMON STOCK | 2022-03-10 | M | A | 4,934 | $5.94 | 8,993 | D | — | — | |
| 3 | Derivative | STOCK OPTION (RIGHT TO BUY) | 2022-03-10 | M | D | 4,934 | $5.94 | 9,869 | D | $5.94 · — to 2028-05-09 | 4,934 COMMON STOCK | (F2) The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. |